Concepedia

Harmen Hawer

HH

Statistics

Publications

3

Citations

90

H-Index

3

Active since

2018

Affiliations

Roche Pharma AG (Germany)(Current)

University of Kassel

Technische Universität Berlin

Harmen Hawer is an author at Roche Pharma AG (Germany) specializing in life sciences, protein translation, and translation factors.

ORCID

Publications per year

2018–2022

3

Publications

3

Diphthamide-deficiency syndrome: a novel human developmental disorder and ribosomopathy

Harmen Hawer, Bryce A. Mendelsohn, Klaus Mayer et al. · European Journal of Human Genetics · 2020 · 38 citations · Full text

, , +16

Importance of diphthamide modified EF2 for translational accuracy and competitive cell growth in yeast

Harmen Hawer, Koray Ütkür, Meike Arend et al. · PLoS ONE · 2018 · 31 citations · Full text

, , +17

Translational fidelity and growth of Arabidopsis require stress-sensitive diphthamide biosynthesis

Hongliang Zhang, Julia Quintana, Koray Ütkür et al. · Nature Communications · 2022 · 21 citations · Full text

, , +17

1–3 of 3